Jordan International Insurance Company (ASE:JIJC)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7	9	9	5	7	9
Market Cap Growth	-14.00%	4.00%	66.67%	-18.92%	-21.28%	14.63%
Enterprise Value	8	11	6	1	-2	3
PS Ratio	0.59	1.64	1.30	0.22	0.56	1.40
PB Ratio	0.45	0.60	0.55	0.31	0.33	0.40
P/FCF Ratio	23.94	-	-	-	2.06	21.83
P/OCF Ratio	22.26	-	-	-	2.03	18.93
EV/Sales Ratio	0.68	1.84	0.84	0.03	-	0.54
EV/EBITDA Ratio	142.10	-	-	-	-	-
EV/FCF Ratio	27.69	-	-	-	-	8.50
Debt / Equity Ratio	0.04	0.03	0.05	0.04	-	-
Quick Ratio	0.09	0.08	0.10	0.09	1.22	1.33
Current Ratio	0.90	0.90	0.91	0.90	1.35	1.47
Asset Turnover	0.26	0.13	0.15	0.57	0.33	0.18
Return on Equity (ROE)	-0.43%	-4.99%	-5.35%	-9.09%	-0.64%	-1.17%
Return on Assets (ROA)	-0.11%	-1.15%	-1.19%	-2.30%	-0.35%	-1.13%
Return on Capital (ROIC)	-0.31%	-3.08%	-3.14%	-5.11%	-0.60%	-1.75%
Earnings Yield	-1.06%	-8.64%	-10.08%	-31.56%	-1.98%	-2.91%
Earnings Yield	-1.06%	-8.64%	-10.08%	-31.56%	-1.98%	-2.91%
FCF Yield	4.18%	-2.48%	-19.67%	-111.36%	48.46%	4.58%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.